Tonix Pharmaceuticals Holding Corp. (TNXP) insider trading.
In Q3 2026, insiders at Tonix Pharmaceuticals Holding Corp. reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 2 open-market purchases worth $40K and 0 sales.
- Transactions
- 3
- Purchases (P)
- 2
- Sales (S)
- 0
- Net shares, P minus S
- 3,000
- Insiders
- 3
- Last filed
- 2026-08-31
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Lederman Seth | Director, Officer · Chief Executive Officer | 1 | 1 | 0 |
| Bagger Richard H | Director | 1 | 1 | 0 |
| Saenger Bradley | Officer · Chief Financial Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-27 | Lederman Seth | P (A) | 2,000 | $13.79 | 11,005 | Form 4 |
| 2026-08-20 | Bagger Richard H | P (A) | 1,000 | $12.6 | 1,000 | Form 4 |
| 2026-06-30 | Saenger Bradley | J (A) | 1,453 | $10.91 | 2,154 | Form 4 |
Transaction codes in this quarter
Get TNXP insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1430306&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TNXP company page · Tonix Pharmaceuticals Holding Corp. on SEC.gov
Questions
Are insiders buying or selling Tonix Pharmaceuticals Holding Corp. (TNXP)?
In Q3 2026, insiders at Tonix Pharmaceuticals Holding Corp. reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 2 open-market purchases worth $40K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Tonix Pharmaceuticals Holding Corp. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tnxp.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.